Angina module 6: secondary prevention and treatment

Released9 April 2020     Expires: 09 April 2022      Programme: Angina 2.5 CPD/CME credits

Heart failure - BJC Learning programme
For healthcare professionals only

A. Menarini Farmaceutica Internazionale SRL has provided an educational grant for the production of this e-learning programme and has had no editorial control or input. The views and content expressed within this programme are solely those of the authors.

PP-CA-UK-0156 Date of preparation: March 2020


Designed to give healthcare professionals a current update on the treatment of angina, this is one of several modules in our angina programme.

Module first published: 06 July 2012
First revision of module published: 04 March 2015
Second revision of module published: 09 April 2020

2.5 CPD/CME credits

Learning objectives

After completing this module, participants should become:
• Identify the objectives for secondary prevention and angina treatment
• Understand the mode of action and clinical profile of antianginal agents
• Know the treatment guidelines and when to use them appropriately


Dr Henry Purcell, Royal Brompton Hospital, London.
Dr Chris Arden, GPwSI in Cardiology, Park Surgery, Chandlers Ford, Southampton.
Module revised by Dr Richard Armstrong, Cardiology Research Fellow, St James Hospital, Dublin, Ireland; supervised by Dr Ranil De Silva, Senior Clinical Lecturer and Honorary Consultant Cardiologist, National Heart and Lung Institute, Imperial College London, Royal Brompton Hospital, London.


2.5 CPD/CME credits, 2.5 hours
BJC Learning has assigned two and a half hours of CPD/CME credit to this module

Endorsed by:

You need to login to take this module

You need to be a registered member to view this page. It's quick, free and offers you a host of other benefits, including the facility to print and download articles and supplements, access our archived issues and receive email updates when new issues and other content are online.

15 thoughts on “Angina module 6: secondary prevention and treatment”

All rights reserved. No part of this programme may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior permission of the publishers, Medinews (Cardiology) Limited.

It shall not, by way of trade or otherwise, be lent, re-sold, hired or otherwise circulated without the publisher’s prior consent.

Medical knowledge is constantly changing. As new information becomes available, changes in treatment, procedures, equipment and the use of drugs becomes necessary. The editors/authors/contributors and the publishers have taken care to ensure that the information given in this text is accurate and up to date. Readers are strongly advised to confirm that the information, especially with regard to drug usage, complies with the latest legislation and standards of practice.

Healthcare professionals should consult up-to-date Prescribing Information and the full Summary of Product Characteristics available from the manufacturers before prescribing any product. Medinews (Cardiology) Limited cannot accept responsibility for any errors in prescribing which may occur.